icd10free.comPowered by Curo

ICD-10 Coding for Metastatic Pancreatic Cancer(C25.9, C78.7, C78.89)

Save

Learn about ICD-10 coding for metastatic pancreatic cancer, including primary and secondary site codes, sequencing rules, and documentation requirements.

Also known as:
Pancreatic Cancer with MetastasisSecondary Pancreatic Cancer
Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Pancreatic Cancer

C00-D49Primary Range

Neoplasms

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C25.9Malignant neoplasm of pancreas, unspecified
C78.89Secondary malignant neoplasm of other specified sites
Primary ICD-10-CM Codes
Malignant neoplasm of pancreas, unspecified
C25.9Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Benign neoplasm of pancreasD13.6
Malignant neoplasm without specification of siteC80.1

Documentation & Coding Risks

Avoid these common issues when documenting Metastatic Pancreatic Cancer.

Using history codes for active treatment

Impact

Clinical: Misrepresentation of active disease status., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement for active treatment.

Mitigation

Verify treatment status before coding., Use active codes until treatment concludes.

Incorrect sequencing of primary and secondary codes

Impact

Reimbursement: Incorrect DRG assignment, affecting reimbursement., Compliance: Non-compliance with ICD-10 sequencing rules., Data Quality: Inaccurate data on cancer treatment focus.

Mitigation

Sequence secondary code first if treatment focus is on metastasis.

Incorrect primary site coding

Impact

Using unspecified codes when primary site is known.

Mitigation

Ensure documentation specifies primary site whenever possible.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with C25.9.